Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...

Add Yahoo as a preferred source to see more of our stories on Google. Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program's price negotiations, touting a total of $12 billion saved ...

The use of GLP-1s like Ozempic and Mounjaro jumped 8 percentage points in the last two years, latest data shows.

At the centre of the market rush is Veradermics’ VDPHL01, investigational extended-release version of oral minoxidil.

Dozens of Ozempic, Mounjaro and Wegovy users are reporting a drug-induced “sunburn” sensation so severe it can make wearing clothes or driving unbearably painful, prompting medical experts to call for ...

Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...

Ozempic was created thanks to research on Gila monsters, the only venomous lizard in the US. Their venom slows digestion and curbs cravings for hours.

Retatrutide, not yet approved by the FDA, is the latest wonder drug to shed pounds despite warnings from doctors ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

After decades of prescription drug prices rising faster than inflation, new data from the Bureau of Labor Statistics offered ...